Bukalapakcom Tbk vs Diagnos Laboratorium Utama Tbk. — how do they compare? Bukalapakcom Tbk trades at Rp106 (market cap 10.32T, 276.01M 24h volume), while Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 310.75B, 963.6K 24h volume). The key difference: Bukalapakcom Tbk is far larger — about 33.2× Diagnos Laboratorium Utama Tbk.'s market cap, and Bukalapakcom Tbk is more actively traded (276.01M versus 963.6K). Which is the better fit depends on your goals.
| BUKA | DGNS | |
|---|---|---|
Market Cap | 10.32T | 310.75B |
Volume | 276.01M | 963.6K |
Lot | 2.76M | 9.64K |
Turnover | 28.91B | 217.67M |
Average Price | 104.72 | 225.89 |
Value | 28.91B | 217.67M |
Indicative Equilibrium Price | 106 | 226 |
Indicative Equilibrium Volume | 109.67K | 1K |
Trailing returns across standard periods
Latest headlines on both assets
PT Bukalapak.com Tbk. (the Company) was established in Indonesia on September 9, 2011 based on Notarial Deed No. 11 on the same date of Dr. Misahardi Wilamarta, S.H., M.H., M.Kn., LL.M.
Read more on BUKA →PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →